Stock Price Quote

JENBURKT PHARMACEUTICALS LTD.

NSE : NABSE : 524731ISIN CODE : INE354A01013Industry : Pharmaceuticals & DrugsHouse : Private
BSE881.75-0.5 (-0.06 %)
PREV CLOSE ( ) 882.25
OPEN PRICE ( ) 888.60
BID PRICE (QTY) 875.50 (1)
OFFER PRICE (QTY) 881.75 (5)
VOLUME 1745
TODAY'S LOW / HIGH ( )845.00 889.95
52 WK LOW / HIGH ( ) 586.9925
NSE
This Company is not listed in NSE
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1985
Management Info
Ashish U Bhuta - Chairman Ashish U Bhuta - Managing Director
Registered Office

Address Nirmala Apartments,93 Jayprakash Road,Andheri (West),
Mumbai,
Maharashtra-400058

Phone 022-67603603

Email investor@jenburkt.com / info@jenburkt.com

Website www.jenburkt.com

Registrars Details
Bigshare Services Pvt Ltd
Office No S6-2, 6th Floor, Pinnacle Business Park,Next to Ahura Centre, Mahakali Caves Road,Andheri (E),Mumbai
Listing : BSE

NEWS

02Mar Jenburkt Pharmaceuticals informs about
In terms of Regulation 39(3) of the Securities and Exchange Board of Ind..
13Dec Jenburkt Pharmaceuticals informs about
Jenburkt Pharmaceuticals has informed that the information received from..
09Aug Jenburkt Pharmaceuticals informs about
Pursuant to Regulation 39(3) of the Securities and Exchange Board of Ind..
14Jul Jenburkt Pharmaceuticals informs about
Pursuant to Regulation 39(3) of the Securities and Exchange Board of Ind..
07Jul Jenburkt Pharmaceuticals informs about
Pursuant to Regulation 39(3) of the Securities and Exchange Board of Ind..

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit78.83259.76
Gross Profit 103.66 351.74
Operating Profit 110.42377.85
Net Sales 388.421419.66

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Neuland Laboratories (BSE)
peergroup  8529.75 (2.69%)
M.Cap ( in Cr)10952.11
Astrazeneca Pharma I (BSE)
peergroup  6712.15 (1.32%)
M.Cap ( in Cr)16772.88
RPG Life Sciences (BSE)
peergroup  1709.90 (4.23%)
M.Cap ( in Cr)2807.33
Pfizer (BSE)
peergroup  5011.75 (1.40%)
M.Cap ( in Cr)22893.31
Abbott India (BSE)
peergroup  28645.70 (0.19%)
M.Cap ( in Cr)60879.14

Shareholding Pattern

NON-INSTITUTION 53.29%
PROMOTERS 46.71%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

About Jenburkt Pharmaceuticals Ltd.

Jenburkt Pharmaceuticals Ltd. was incorporated in the year 1985. Its today's share price is 881.75. Its current market capitalisation stands at Rs 388.3 Cr. In the latest quarter, company has reported Gross Sales of Rs. 1419.67 Cr and Total Income of Rs.1466.33 Cr. The company's management includes Pankaj A Dantwala, Krishnan Subharaman, Sumit A Thakkar, Hina R Mehta, Dilip H Bhuta, Ashish U Bhuta, Ashish U Bhuta, Ashish R Shah.

It is listed on the BSE with a BSE Code of 524731 , NSE with an NSE Symbol of and ISIN of INE354A01013. It's Registered office is at Nirmala Apartments,93 Jayprakash Road,Andheri (West)Mumbai-400058, Maharashtra. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are DL Arora & Co, DR Mehta & Associates

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.